Can you provide the last earnings date for FORTE BIOSCIENCES INC?
FORTE BIOSCIENCES INC (FBRX) last reported earnings on 11/14/2025.
NASDAQ:FBRX • US34962G2084
Past quarterly earnings results for FORTE BIOSCIENCES INC (FBRX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.99 | -1.09 | 9.08% | 78.19% | - | - | ||
| Q2 2025 | -0.96 | -1.13 | 15.02% | 85.78% | - | - | ||
| Q1 2025 | -1.37 | -0.97 | -41.38% | 65.75% | - | - | ||
| Q4 2024 | -2.45 | -3.34 | 26.55% | 47.31% | - | - | ||
| Q3 2024 | -4.54 | -7.27 | 37.53% | -1,646.15% | - | - | ||
| Q2 2024 | -6.75 | -4.25 | -58.82% | -1,507.14% | - | - | ||
| Q1 2024 | -4.00 | -4.21 | 4.93% | - | - | - | ||
| Q4 2023 | -4.65 | -7.14 | 34.88% | -2,749.11% | - | - | ||
| Q3 2023 | -0.26 | - | 94.22% | - | - | |||
| Q2 2023 | -0.42 | - | -100.00% | - | - | |||
| Q1 2023 | - | - | - | - | ||||
| Q4 2022 | -0.16 | - | 96.89% | - | - | |||
| Q3 2022 | -4.50 | -3.83 | -17.65% | 66.67% | - | - | ||
| Q2 2022 | -0.21 | -0.19 | -8.36% | 98.05% | - | - | ||
| Q1 2022 | -0.20 | - | 97.73% | - | - | |||
| Q4 2021 | -5.25 | -8.16 | 35.66% | 43.24% | - | - | ||
| Q3 2021 | -13.50 | -9.31 | -45.04% | -20.00% | - | - | ||
| Q2 2021 | -10.75 | -11.03 | 2.53% | 95.48% | - | - | ||
| Q1 2021 | -9.00 | -13.39 | 32.77% | 94.42% | - | - | ||
| Q4 2020 | -9.25 | -14.62 | 36.73% | - | - | - | ||
| Q3 2020 | -11.25 | -13.77 | 18.30% | - | - | - | ||
| Q2 2020 | -238.00 | -4.85 | -4,812.28% | - | - | - | ||
| Q1 2020 | -161.25 | -168.30 | 4.19% | - | - | - |
Notes
FORTE BIOSCIENCES INC (FBRX) last reported earnings on 11/14/2025.
FORTE BIOSCIENCES INC (FBRX) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, FORTE BIOSCIENCES INC (FBRX) has beaten EPS estimates in 3 out of 4 releases.